FDA-approved epilepsy drug may help reverse osteoarthritis damage
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward rep
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward rep This story matters for Health & Wellness readers tracking gym. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. GymNews.com curates and briefs the health & wellness stories that matter. Our editorial policy →
Get the daily gym signal